Evidence map›Paper›PMID 35335130›Full record

ReviewMolecules (Basel, Switzerland)2022

Phenolics as GABA

José-Luis Ríos, Guillermo R Schinella, Inés Moragrega

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Marine drugs · 2026
    Article
  6. Green-synthesizedRSC advances · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Genistein and Vanadate Differentially Modulate Cortical GABAInternational journal of molecular sciences · 2025
    Article
  13. GABAPharmaceuticals (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Current issues in molecular biology · 2024
    Article
  18. Review
  19. Phenols and GABAFrontiers in pharmacology · 2024
    Review
  20. Dual Modulator of ASIC Channels and GABAInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

José-Luis RíosDepartament de Farmacologia, Facultat de Farmàcia, Universitat de València, Av. Vicent Andrés Estellés s/n, Burjassot, 46100 Valencia, Spain.
Guillermo R SchinellaFacultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata BA1900, Argentina.ORCID 0000-0001-9541-9688
Inés MoragregaDepartament de Psicobiologia, Facultat de Psicologia, Universitat de València, Av. Blasco Ibáñez 21, 46010 Valencia, Spain.
Universitat de València · ESInstituto de Investigaciones en Ciencias de la Salud · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products can act as potential GABA modulators, avoiding the undesirable effects of traditional pharmacology used for the inhibition of the central nervous system such as benzodiazepines (BZD). Phenolics, especially flavonoids and phlorotannins, have been considered as modulators of the BZD-site of GABA

Indexed as

GABA ModulatorsReceptors, GABA-ABenzodiazepinesBinding SitesLigandsBenzodiazepinesGABA ModulatorsLigandsReceptors, GABA-ACNS pathologiesflavonoidsGABAGABAAR modulatorsphenolicsphlorotannins

Identifiers

PMID35335130
PMCPMC8953830
OpenAlexW4220783713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.